Gonococcal infection of other musculoskeletal tissue
ICD-10 A54.49 is a billable code used to indicate a diagnosis of gonococcal infection of other musculoskeletal tissue.
Gonococcal infection of other musculoskeletal tissue refers to an infection caused by the bacterium Neisseria gonorrhoeae, which primarily affects the mucous membranes of the urogenital tract but can also involve other tissues, including the musculoskeletal system. This condition may manifest as septic arthritis or tenosynovitis, particularly in sexually active individuals. The infection can lead to inflammation, pain, and swelling in the affected joints or soft tissues. Gonococcal infections are classified as sexually transmitted infections (STIs) and can be asymptomatic in many cases, particularly in women. Diagnosis typically involves culture or nucleic acid amplification tests (NAATs) from the site of infection. Treatment usually includes antibiotics, with dual therapy recommended to cover potential co-infection with Chlamydia trachomatis. Contact tracing is crucial to prevent further transmission, as gonococcal infections can spread rapidly among sexual partners. Public health guidelines emphasize the importance of screening and treating all sexual partners of infected individuals to control the spread of this STI.
Detailed patient history, including sexual history and symptoms, laboratory results, and treatment plans.
Patients presenting with joint pain, swelling, and fever, particularly in sexually active individuals.
Consideration of co-infections and the need for comprehensive STI screening.
Clinical notes detailing joint examination findings, imaging results, and treatment interventions.
Patients with septic arthritis or tenosynovitis requiring surgical intervention or joint aspiration.
Documentation must clearly differentiate between infectious and non-infectious causes of joint pain.
Used when testing for gonococcal infection in symptomatic patients.
Document the reason for testing and the patient's symptoms.
Infectious disease specialists should ensure comprehensive STI screening.
Common symptoms include joint pain, swelling, fever, and in some cases, purulent discharge if the infection is disseminated.
Diagnosis is typically made through culture or nucleic acid amplification tests (NAATs) from the affected site, along with clinical evaluation.
The CDC recommends dual therapy with ceftriaxone and azithromycin to effectively treat gonococcal infections and cover potential co-infections.
